TIAA CREF Investment Management’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | $45.1M | Buy |
310,779
+111,076
| +56% | +$14.6M | 0.03% | 430 |
|
|
2018
Q4 | $22.6M | Buy |
199,703
+5,841
| +3% | +$731K | 0.02% | 609 |
|
|
2018
Q3 | $26.1M | Buy |
193,862
+9,749
| +5% | +$1.2M | 0.02% | 633 |
|
|
2018
Q2 | $20.7M | Buy |
184,113
+3,593
| +2% | +$388K | 0.01% | 723 |
|
|
2018
Q1 | $19.3M | Sell |
180,520
-140,972
| -44% | -$15.2M | 0.01% | 778 |
|
|
2017
Q4 | $35.2M | Sell |
321,492
-44,099
| -12% | -$4.8M | 0.02% | 553 |
|
|
2017
Q3 | $39.5M | Buy |
365,591
+53,942
| +17% | +$5.54M | 0.03% | 516 |
|
|
2017
Q2 | $31.5M | Sell |
311,649
-60,714
| -16% | -$5.59M | 0.02% | 578 |
|
|
2017
Q1 | $33.5M | Sell |
372,363
-8,955
| -2% | -$761K | 0.02% | 561 |
|
|
2016
Q4 | $29.1M | Buy |
381,318
+134,301
| +54% | +$10.2M | 0.02% | 610 |
|
|
2016
Q3 | $20.6K | Sell |
247,017
-160,084
| -39% | -$13.4M | 0.01% | 762 |
|
|
2016
Q2 | $33.6M | Buy |
407,101
+94,180
| +30% | +$7.76M | 0.03% | 549 |
|
|
2016
Q1 | $23.8M | Buy |
312,921
+51,097
| +20% | +$3.78M | 0.02% | 682 |
|
|
2015
Q4 | $21M | Buy |
261,824
+39,173
| +18% | +$2.83M | 0.02% | 738 |
|
|
2015
Q3 | $14.1M | Buy |
222,651
+59,960
| +37% | +$4.31M | 0.01% | 868 |
|
|
2015
Q2 | $11.4M | Sell |
162,691
-82,547
| -34% | -$6.11M | 0.01% | 1059 |
|
|
2015
Q1 | $19.4M | Buy |
245,238
+96,144
| +64% | +$7.09M | 0.01% | 792 |
|
|
2014
Q4 | $9.49M | Buy |
149,094
+48,483
| +48% | +$3.04M | 0.01% | 1147 |
|
|
2014
Q3 | $6.01M | Sell |
100,611
-175,956
| -64% | -$10.1M | ﹤0.01% | 1474 |
|
|
2014
Q2 | $14.8M | Sell |
276,567
-44,520
| -14% | -$2.44M | 0.01% | 921 |
|
|
2014
Q1 | $19.4M | Buy |
321,087
+35,435
| +12% | +$2.07M | 0.01% | 808 |
|
|
2013
Q4 | $15.2M | Buy |
285,652
+82,451
| +41% | +$4.14M | 0.01% | 913 |
|
|
2013
Q3 | $9.4M | Buy |
203,201
+100,122
| +97% | +$4.59M | 0.01% | 1126 |
|
|
2013
Q2 | $4.23M | Buy |
+103,079
| New | +$4.42M | ﹤0.01% | 1647 |
|
Other funds holding CRL
TCM